» Articles » PMID: 28593447

Predictors of Near-term Fracture in Osteoporotic Women Aged ≥65 years, Based on Data from the Study of Osteoporotic Fractures

Overview
Journal Osteoporos Int
Date 2017 Jun 9
PMID 28593447
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: While several risk factors are known to contribute to long-term fracture risk in women with osteoporosis, factors predicting fracture risk over a shorter time horizon, such as over a 1-year period, are less well-established.

Methods: We utilized a repeated-observations design and data from the Study of Osteoporotic Fractures to identify factors contributing to near-term risk of hip fracture and any non-vertebral fracture, respectively, among osteoporotic women aged ≥65 years. Potential predictors of hip fracture and any non-vertebral fracture over the 1-year period subsequent to each qualifying SOF exam were examined using multivariable frailty models. Because the discriminative ability of the hip fracture model was acceptable, a corresponding risk-prediction tool was also developed.

Results: Study population included 2499 women with osteoporosis, who contributed 6811 observations. Incidence of fracture in the 1-year period subsequent to each exam was 2.2% for hip fracture and 6.6% for any non-vertebral fracture. Independent predictors of hip fracture included low total hip T-score, prior fracture, and risk factors for falls (multivariable model c-statistic = 0.71 (95% CI 0.67-0.76)). Independent predictors of any non-vertebral fracture included age, total hip T-score, prior falls, prior fracture, walking speed, Parkinson's disease or stroke, and smoking (multivariable model c-statistic = 0.62 (0.59-0.65)).

Conclusions: Several clinical characteristics predictive of hip and non-vertebral fracture within a 1-year follow-up period among elderly women with osteoporosis were identified, and a subset of those for hip fracture was incorporated into a risk assessment tool. Assessment of these risk factors may help guide osteoporosis treatment choices by identifying patients in whom there is urgency to treat. Additional research is needed to validate the findings of this study and the accuracy of the risk assessment tool.

Citing Articles

Development and validation of a predictive model for vertebral fracture risk in osteoporosis patients.

Zhang J, Xia L, Zhang X, Liu J, Tang J, Xia J Eur Spine J. 2024; 33(8):3242-3260.

PMID: 38955868 DOI: 10.1007/s00586-024-08235-4.


The development and validation of a prediction model for imminent vertebral osteoporotic fracture in postmenopausal women.

Lin S, Luo Y, Xie Y, Liao Y, Niu S, Zheng Y Eur Spine J. 2024; .

PMID: 38844587 DOI: 10.1007/s00586-024-08333-3.


A meta-analysis of previous falls and subsequent fracture risk in cohort studies.

Vandenput L, Johansson H, McCloskey E, Liu E, Schini M, Akesson K Osteoporos Int. 2024; 35(3):469-494.

PMID: 38228807 DOI: 10.1007/s00198-023-07012-1.


Osteoporosis - An Imminent Ethical and Legal Debacle?.

Pai S, Jeyaraman N, Jeyaraman M, Shyam A J Orthop Case Rep. 2023; 13(9):1-3.

PMID: 37753139 PMC: 10519322. DOI: 10.13107/jocr.2023.v13.i09.3852.


Executive summary: Italian guidelines for diagnosis, risk stratification, and care continuity of fragility fractures 2021.

Corrao G, Biffi A, Porcu G, Ronco R, Adami G, Alvaro R Front Endocrinol (Lausanne). 2023; 14:1137671.

PMID: 37143730 PMC: 10151776. DOI: 10.3389/fendo.2023.1137671.


References
1.
DAgostino Sr R, Vasan R, Pencina M, Wolf P, Cobain M, Massaro J . General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation. 2008; 117(6):743-53. DOI: 10.1161/CIRCULATIONAHA.107.699579. View

2.
Langsetmo L, Nguyen T, Nguyen N, Kovacs C, Prior J, Center J . Independent external validation of nomograms for predicting risk of low-trauma fracture and hip fracture. CMAJ. 2010; 183(2):E107-14. PMC: 3033952. DOI: 10.1503/cmaj.100458. View

3.
Pencina M, DAgostino Sr R, DAgostino Jr R, Vasan R . Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med. 2007; 27(2):157-72. DOI: 10.1002/sim.2929. View

4.
du Bois R, Weycker D, Albera C, Bradford W, Costabel U, Kartashov A . Ascertainment of individual risk of mortality for patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2011; 184(4):459-66. DOI: 10.1164/rccm.201011-1790OC. View

5.
Cook N, Buring J, Ridker P . The effect of including C-reactive protein in cardiovascular risk prediction models for women. Ann Intern Med. 2006; 145(1):21-9. DOI: 10.7326/0003-4819-145-1-200607040-00128. View